A股異動丨中來股份(300393.SZ)高開逾8% 子公司泰州中來生產的TOPCon電池量產轉換效率已達到24.5%
格隆匯12月10日丨中來股份(300393.SZ)高開逾8%,報9.58元,總市值74.56億元。中來股份(300393.SZ)公佈,公司控股子公司泰州中來光電科技有限公司(“泰州中來”)於近期在N型單晶電池量產效率方面取得了重大進展,泰州中來生產的TOPCon電池量產轉換效率已達到24.5%,這是國內最高的量產效率。該轉換效率的突破是公司在N型單晶領域長期堅持自主創新的結果,也為公司下一步實現轉換效率25%的目標和產能擴張提供了堅實的基礎。在進一步提升公司內在核心競爭力的同時,將有力推動光伏行業技術的持續進步,推進光伏行業整體持續發展。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.